116 related articles for article (PubMed ID: 12555991)
1. Molecular tumour clocks and colorectal cancer: seeing the unseen.
Shibata D
Pathology; 2002 Dec; 34(6):534-40. PubMed ID: 12555991
[TBL] [Abstract][Full Text] [Related]
2. Stem cells as common ancestors in a colorectal cancer ancestral tree.
Shibata D
Curr Opin Gastroenterol; 2008 Jan; 24(1):59-63. PubMed ID: 18043234
[TBL] [Abstract][Full Text] [Related]
3. The dynamics of early intestinal tumour proliferation: to be or not to be.
Shibata D
Cancer Surv; 1998; 32():181-200. PubMed ID: 10489628
[TBL] [Abstract][Full Text] [Related]
4. Ischemia-induced K-ras mutations in human colorectal cancer cells: role of microenvironmental regulation of MSH2 expression.
Shahrzad S; Quayle L; Stone C; Plumb C; Shirasawa S; Rak JW; Coomber BL
Cancer Res; 2005 Sep; 65(18):8134-41. PubMed ID: 16166287
[TBL] [Abstract][Full Text] [Related]
5. Genomic instability, DNA methylation, and natural selection in colorectal carcinogenesis.
Breivik J; Gaudernack G
Semin Cancer Biol; 1999 Aug; 9(4):245-54. PubMed ID: 10448112
[TBL] [Abstract][Full Text] [Related]
6. [Problems and prospects of non-invasive screening for colorectal cancer].
Maev IV; Govorun VM; Kucheriavyĭ IuA; Golubev NN; Generozov EV; Maslov VV; LiubeznovA IIu; Kostin PA
Klin Med (Mosk); 2009; 87(7):10-6. PubMed ID: 19705783
[TBL] [Abstract][Full Text] [Related]
7. Explaining the familial colorectal cancer risk associated with mismatch repair (MMR)-deficient and MMR-stable tumors.
Aaltonen L; Johns L; Järvinen H; Mecklin JP; Houlston R
Clin Cancer Res; 2007 Jan; 13(1):356-61. PubMed ID: 17200375
[TBL] [Abstract][Full Text] [Related]
8. Frequent alteration of DNA damage signalling and repair pathways in human colorectal cancers with microsatellite instability.
Miquel C; Jacob S; Grandjouan S; Aimé A; Viguier J; Sabourin JC; Sarasin A; Duval A; Praz F
Oncogene; 2007 Aug; 26(40):5919-26. PubMed ID: 17384679
[TBL] [Abstract][Full Text] [Related]
9. Analysis of genetic alterations, classified according to their DNA ploidy pattern, in the progression of colorectal adenomas and early colorectal carcinomas.
Sugai T; Takahashi H; Habano W; Nakamura S; Sato K; Orii S; Suzuki K
J Pathol; 2003 Jun; 200(2):168-76. PubMed ID: 12754737
[TBL] [Abstract][Full Text] [Related]
10. [Epigenetic alterations in colorectal carcinomas and precancerous lesions].
Tischoff I; Tannapfel A
Z Gastroenterol; 2008 Oct; 46(10):1202-6. PubMed ID: 18937191
[TBL] [Abstract][Full Text] [Related]
11. [Prevention of cancer and the dose-effect relationship: the carcinogenic effects of ionizing radiations].
Tubiana M
Cancer Radiother; 2009 Jul; 13(4):238-58. PubMed ID: 19539515
[TBL] [Abstract][Full Text] [Related]
12. Is the gene encoding Chibby implicated as a tumour suppressor in colorectal cancer ?
Gad S; Teboul D; Lièvre A; Goasguen N; Berger A; Beaune P; Laurent-Puig P
BMC Cancer; 2004 Jul; 4():31. PubMed ID: 15245581
[TBL] [Abstract][Full Text] [Related]
13. Recent pathology related advances in colorectal adenocarcinomas.
Goldstein NS
Eur J Surg Oncol; 2001 Aug; 27(5):446-50. PubMed ID: 11504513
[TBL] [Abstract][Full Text] [Related]
14. Exon 3 beta-catenin mutations are specifically associated with colorectal carcinomas in hereditary non-polyposis colorectal cancer syndrome.
Johnson V; Volikos E; Halford SE; Eftekhar Sadat ET; Popat S; Talbot I; Truninger K; Martin J; Jass J; Houlston R; Atkin W; Tomlinson IP; Silver AR
Gut; 2005 Feb; 54(2):264-7. PubMed ID: 15647192
[TBL] [Abstract][Full Text] [Related]
15. Molecular heterogeneity of colorectal cancer: Implications for cancer control.
Jass JR
Surg Oncol; 2007 Dec; 16 Suppl 1():S7-9. PubMed ID: 18023574
[TBL] [Abstract][Full Text] [Related]
16. Identification of critical residues required for the mutation avoidance function of human MutY (hMYH) and implications in colorectal cancer.
Wooden SH; Bassett HM; Wood TG; McCullough AK
Cancer Lett; 2004 Mar; 205(1):89-95. PubMed ID: 15036665
[TBL] [Abstract][Full Text] [Related]
17. Aberrant crypt foci as precursors of the dysplasia-carcinoma sequence in patients with ulcerative colitis.
Kukitsu T; Takayama T; Miyanishi K; Nobuoka A; Katsuki S; Sato Y; Takimoto R; Matsunaga T; Kato J; Sonoda T; Sakamaki S; Niitsu Y
Clin Cancer Res; 2008 Jan; 14(1):48-54. PubMed ID: 18172251
[TBL] [Abstract][Full Text] [Related]
18. Mismatch repair status in the prediction of benefit from adjuvant fluorouracil chemotherapy in colorectal cancer.
Jover R; Zapater P; Castells A; Llor X; Andreu M; Cubiella J; Piñol V; Xicola RM; Bujanda L; Reñé JM; Clofent J; Bessa X; Morillas JD; Nicolás-Pérez D; Payá A; Alenda C;
Gut; 2006 Jun; 55(6):848-55. PubMed ID: 16299036
[TBL] [Abstract][Full Text] [Related]
19. Reduced likelihood of metastases in patients with microsatellite-unstable colorectal cancer.
Malesci A; Laghi L; Bianchi P; Delconte G; Randolph A; Torri V; Carnaghi C; Doci R; Rosati R; Montorsi M; Roncalli M; Gennari L; Santoro A
Clin Cancer Res; 2007 Jul; 13(13):3831-9. PubMed ID: 17606714
[TBL] [Abstract][Full Text] [Related]
20. Mesalazine improves replication fidelity in cultured colorectal cells.
Gasche C; Goel A; Natarajan L; Boland CR
Cancer Res; 2005 May; 65(10):3993-7. PubMed ID: 15899787
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
